130 related articles for article (PubMed ID: 31143302)
1. Induced pluripotent stem cells representing Nakajo-Nishimura syndrome.
Kanazawa N; Honda-Ozaki F; Saito MK
Inflamm Regen; 2019; 39():11. PubMed ID: 31143302
[TBL] [Abstract][Full Text] [Related]
2. Pluripotent Stem Cell Model of Nakajo-Nishimura Syndrome Untangles Proinflammatory Pathways Mediated by Oxidative Stress.
Honda-Ozaki F; Terashima M; Niwa A; Saiki N; Kawasaki Y; Ito H; Hotta A; Nagahashi A; Igura K; Asaka I; Li HL; Yanagimachi M; Furukawa F; Kanazawa N; Nakahata T; Saito MK
Stem Cell Reports; 2018 Jun; 10(6):1835-1850. PubMed ID: 29731430
[TBL] [Abstract][Full Text] [Related]
3. Nakajo-Nishimura syndrome and related proteasome-associated autoinflammatory syndromes.
Ohmura K
J Inflamm Res; 2019; 12():259-265. PubMed ID: 31576159
[TBL] [Abstract][Full Text] [Related]
4. Nakajo-Nishimura syndrome: an autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy.
Kanazawa N
Allergol Int; 2012 Jun; 61(2):197-206. PubMed ID: 22441638
[TBL] [Abstract][Full Text] [Related]
5. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome.
Arima K; Kinoshita A; Mishima H; Kanazawa N; Kaneko T; Mizushima T; Ichinose K; Nakamura H; Tsujino A; Kawakami A; Matsunaka M; Kasagi S; Kawano S; Kumagai S; Ohmura K; Mimori T; Hirano M; Ueno S; Tanaka K; Tanaka M; Toyoshima I; Sugino H; Yamakawa A; Tanaka K; Niikawa N; Furukawa F; Murata S; Eguchi K; Ida H; Yoshiura K
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14914-9. PubMed ID: 21852578
[TBL] [Abstract][Full Text] [Related]
6. Pluripotent stem cell-based screening identifies CUDC-907 as an effective compound for restoring the in vitro phenotype of Nakajo-Nishimura syndrome.
Kase N; Terashima M; Ohta A; Niwa A; Honda-Ozaki F; Kawasaki Y; Nakahata T; Kanazawa N; Saito MK
Stem Cells Transl Med; 2021 Mar; 10(3):455-464. PubMed ID: 33280267
[TBL] [Abstract][Full Text] [Related]
7. A new infant case of Nakajo-Nishimura syndrome with a genetic mutation in the immunoproteasome subunit: an overlapping entity with JMP and CANDLE syndrome related to PSMB8 mutations.
Kunimoto K; Kimura A; Uede K; Okuda M; Aoyagi N; Furukawa F; Kanazawa N
Dermatology; 2013; 227(1):26-30. PubMed ID: 23942189
[TBL] [Abstract][Full Text] [Related]
8. Myositis with sarcoplasmic inclusions in Nakajo-Nishimura syndrome: a genetic inflammatory myopathy.
Ayaki T; Murata K; Kanazawa N; Uruha A; Ohmura K; Sugie K; Kasagi S; Li F; Mori M; Nakajima R; Sasai T; Nishino I; Ueno S; Urushitani M; Furukawa F; Ito H; Takahashi R
Neuropathol Appl Neurobiol; 2020 Oct; 46(6):579-587. PubMed ID: 32144790
[TBL] [Abstract][Full Text] [Related]
9. [Nakajo-Nishimura syndrome].
Kanazawa N; Arima K; Ida H; Yoshiura K; Furukawa F
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):388-400. PubMed ID: 22041427
[TBL] [Abstract][Full Text] [Related]
10. Nakajo-Nishimura Syndrome: The First African Case.
Ghodbane NE; Mecibah A; Merzougui Z; Zerguine H; Akakba Z; Slimani S
Mediterr J Rheumatol; 2023 Jun; 34(2):262-265. PubMed ID: 37654638
[TBL] [Abstract][Full Text] [Related]
11. A Chinese case of Nakajo-Nishimura syndrome with novel compound heterozygous mutations of the PSMB8 gene.
Jia T; Zheng Y; Feng C; Yang T; Geng S
BMC Med Genet; 2020 Jun; 21(1):126. PubMed ID: 32513120
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitor-associated histiocytoid Sweet's syndrome: Clinical and histological similarities to Nakajo-Nishimura syndrome suggest a potential mechanism.
Cho R; Nakajima S; Kaku Y; Tezuka J; Fujimoto M; Kambe N; Kabashima K
J Dermatol; 2024 Apr; ():. PubMed ID: 38558105
[TBL] [Abstract][Full Text] [Related]
13. Genetics of proteasome diseases.
Gomes AV
Scientifica (Cairo); 2013; 2013():637629. PubMed ID: 24490108
[TBL] [Abstract][Full Text] [Related]
14. Rare hereditary autoinflammatory disorders: towards an understanding of critical in vivo inflammatory pathways.
Kanazawa N
J Dermatol Sci; 2012 Jun; 66(3):183-9. PubMed ID: 22336993
[TBL] [Abstract][Full Text] [Related]
15. Proteasome-associated autoinflammatory syndromes: advances in pathogeneses, clinical presentations, diagnosis, and management.
McDermott A; Jacks J; Kessler M; Emanuel PD; Gao L
Int J Dermatol; 2015 Feb; 54(2):121-9. PubMed ID: 25521013
[TBL] [Abstract][Full Text] [Related]
16. Dysfunctional immunoproteasomes in autoinflammatory diseases.
Arimochi H; Sasaki Y; Kitamura A; Yasutomo K
Inflamm Regen; 2016; 36():13. PubMed ID: 29259686
[TBL] [Abstract][Full Text] [Related]
17. Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity.
Liu Y; Ramot Y; Torrelo A; Paller AS; Si N; Babay S; Kim PW; Sheikh A; Lee CC; Chen Y; Vera A; Zhang X; Goldbach-Mansky R; Zlotogorski A
Arthritis Rheum; 2012 Mar; 64(3):895-907. PubMed ID: 21953331
[TBL] [Abstract][Full Text] [Related]
18. Pluripotent stem cell models of Blau syndrome reveal an IFN-γ-dependent inflammatory response in macrophages.
Takada S; Kambe N; Kawasaki Y; Niwa A; Honda-Ozaki F; Kobayashi K; Osawa M; Nagahashi A; Semi K; Hotta A; Asaka I; Yamada Y; Nishikomori R; Heike T; Matsue H; Nakahata T; Saito MK
J Allergy Clin Immunol; 2018 Jan; 141(1):339-349.e11. PubMed ID: 28587749
[TBL] [Abstract][Full Text] [Related]
19. Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.
Brehm A; Liu Y; Sheikh A; Marrero B; Omoyinmi E; Zhou Q; Montealegre G; Biancotto A; Reinhardt A; Almeida de Jesus A; Pelletier M; Tsai WL; Remmers EF; Kardava L; Hill S; Kim H; Lachmann HJ; Megarbane A; Chae JJ; Brady J; Castillo RD; Brown D; Casano AV; Gao L; Chapelle D; Huang Y; Stone D; Chen Y; Sotzny F; Lee CC; Kastner DL; Torrelo A; Zlotogorski A; Moir S; Gadina M; McCoy P; Wesley R; Rother KI; Hildebrand PW; Brogan P; Krüger E; Aksentijevich I; Goldbach-Mansky R
J Clin Invest; 2015 Nov; 125(11):4196-211. PubMed ID: 26524591
[TBL] [Abstract][Full Text] [Related]
20. Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases.
Tanaka T; Shiba T; Honda Y; Izawa K; Yasumi T; Saito MK; Nishikomori R
Front Immunol; 2022; 13():870535. PubMed ID: 35603217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
